| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ALK5/VEGFR2 dual inhibitor TU2218 alone or in combination with immune checkpoint inhibitors enhances immune-mediated antitumor effects
|
Kim, Nam-Hoon
|
|
|
73 |
10 |
|
artikel
|
| 2 |
Anlotinib reversed resistance to PD-1 inhibitors in recurrent and metastatic head and neck cancers: a real-world retrospective study
|
Jiang, Jianyun
|
|
|
73 |
10 |
|
artikel
|
| 3 |
CD27 signaling inhibits tumor growth and metastasis via CD8 + T cell-independent mechanisms in the B16-F10 melanoma model
|
Puppala, Eswara Rao
|
|
|
73 |
10 |
|
artikel
|
| 4 |
Chimeric antigen receptor dendritic cells targeted delivery of a single tumoricidal factor for cancer immunotherapy
|
Duan, Rong
|
|
|
73 |
10 |
|
artikel
|
| 5 |
Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series
|
Muddasani, Ramya
|
|
|
73 |
10 |
|
artikel
|
| 6 |
Conversion of anti-tissue factor antibody sequences to chimeric antigen receptor and bi-specific T-cell engager format
|
Saunderson, S. C.
|
|
|
73 |
10 |
|
artikel
|
| 7 |
Deciphering the interplay of HPV infection, MHC-II expression, and CXCL13+ CD4+ T cell activation in oropharyngeal cancer: implications for immunotherapy
|
Yan, Shida
|
|
|
73 |
10 |
|
artikel
|
| 8 |
DNA hypo-methylation and expression of GBP4 induces T cell exhaustion in pancreatic cancer
|
Tasiheng, Yesiboli
|
|
|
73 |
10 |
|
artikel
|
| 9 |
First-line treatment with KN046, chemotherapy and palliative radiotherapy for advanced esophageal squamous cell carcinoma: an open-label, dose escalation, and dose expansion phase Ib trial
|
Zhao, Qi
|
|
|
73 |
10 |
|
artikel
|
| 10 |
Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancer
|
Park, Changhee
|
|
|
73 |
10 |
|
artikel
|
| 11 |
GP100 expression is variable in intensity in melanoma
|
Mann, Jacqueline E.
|
|
|
73 |
10 |
|
artikel
|
| 12 |
Highlighting immune features of the tumor ecosystem and prognostic value of Tfh and Th17 cell infiltration in head and neck squamous cell carcinoma by single-cell RNA-seq
|
Tian, Yan
|
|
|
73 |
10 |
|
artikel
|
| 13 |
Hypofractionated radiotherapy plus PD-1 antibody and SOX chemotherapy as second-line therapy in metastatic pancreatic cancer: a single-arm, phase II clinical trial
|
Wang, Qin
|
|
|
73 |
10 |
|
artikel
|
| 14 |
Impact of the interval between neoadjuvant immunotherapy and surgery on prognosis in esophageal squamous cell carcinoma (ESCC): a real-world study
|
Yang, Guozhen
|
|
|
73 |
10 |
|
artikel
|
| 15 |
Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma
|
Wu, Huantong
|
|
|
73 |
10 |
|
artikel
|
| 16 |
Negative association of steroids with immunotherapy efficacy in a multi-tumor cohort: time and dose-dependent
|
Albarrán, Víctor
|
|
|
73 |
10 |
|
artikel
|
| 17 |
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity
|
Herault, Aurelie
|
|
|
73 |
10 |
|
artikel
|
| 18 |
Preclinical development of a novel CCR8/CTLA-4 bispecific antibody for cancer treatment by disrupting CTLA-4 signaling on CD8 T cells and specifically depleting tumor-resident Tregs
|
Guo, Cuicui
|
|
|
73 |
10 |
|
artikel
|
| 19 |
Predicting recurrent glioblastoma clinical outcome to immune checkpoint inhibition and low-dose bevacizumab with tumor in situ fluid circulating tumor DNA analysis
|
Guo, Guangzhong
|
|
|
73 |
10 |
|
artikel
|
| 20 |
Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors
|
Geva, Ravit
|
|
|
73 |
10 |
|
artikel
|
| 21 |
Spatial cell interplay networks of regulatory T cells predict recurrence in patients with operable non-small cell lung cancer
|
Cai, Siqi
|
|
|
73 |
10 |
|
artikel
|
| 22 |
Targeting PI3K-gamma in myeloid driven tumour immune suppression: a systematic review and meta-analysis of the preclinical literature
|
Xu, Haonan
|
|
|
73 |
10 |
|
artikel
|
| 23 |
The expression of PD-L1 on tumor-derived exosomes enhances infiltration and anti-tumor activity of αCD3 × αPD-L1 bispecific antibody-armed T cells
|
Cho, Jaewon
|
|
|
73 |
10 |
|
artikel
|
| 24 |
TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3
|
Perales, Oscar
|
|
|
73 |
10 |
|
artikel
|
| 25 |
Unlocking the potential of HHLA2: identifying functional immune infiltrating cells in the tumor microenvironment and predicting clinical outcomes in laryngeal squamous cell carcinoma
|
Li, Wenjing
|
|
|
73 |
10 |
|
artikel
|
Tijdschrift beschrijving